| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |